127 related articles for article (PubMed ID: 27389030)
1. Specific MAPK inhibitors prevent hyperglycemia-induced renal diseases in type 1 diabetic mouse model.
Hong Z; Hong Z; Wu D; Nie H
Mol Cell Biochem; 2016 Aug; 419(1-2):1-9. PubMed ID: 27389030
[TBL] [Abstract][Full Text] [Related]
2. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.
Pan Y; Huang Y; Wang Z; Fang Q; Sun Y; Tong C; Peng K; Wang Y; Miao L; Cai L; Zhao Y; Liang G
J Cell Mol Med; 2014 Feb; 18(2):231-41. PubMed ID: 24330074
[TBL] [Abstract][Full Text] [Related]
4. Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.
Wang T; Chen SS; Chen R; Yu DM; Yu P
Int J Clin Exp Pathol; 2015; 8(3):2321-33. PubMed ID: 26045739
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
6. Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells.
Ahad A; Ahsan H; Mujeeb M; Siddiqui WA
Chem Biol Interact; 2015 Oct; 240():292-303. PubMed ID: 26341651
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of inflammatory response by a novel chalcone protects kidney and heart from hyperglycemia-induced injuries in type 1 diabetic mice.
Fang Q; Wang J; Wang L; Zhang Y; Yin H; Li Y; Tong C; Liang G; Zheng C
Toxicol Appl Pharmacol; 2015 Oct; 288(2):179-91. PubMed ID: 26206226
[TBL] [Abstract][Full Text] [Related]
8. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.
Kuo CW; Shen CJ; Tung YT; Chen HL; Chen YH; Chang WH; Cheng KC; Yang SH; Chen CM
Life Sci; 2015 Aug; 135():77-86. PubMed ID: 26006040
[TBL] [Abstract][Full Text] [Related]
9. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
[TBL] [Abstract][Full Text] [Related]
10. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
Motawi TK; El-Maraghy SA; Senousy MA
J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
[TBL] [Abstract][Full Text] [Related]
12. Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice.
Lakshmanan AP; Thandavarayan RA; Watanabe K; Sari FR; Meilei H; Giridharan VV; Sukumaran V; Soetikno V; Arumugam S; Suzuki K; Kodama M
Mol Cell Endocrinol; 2012 Jan; 348(1):104-11. PubMed ID: 21827824
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease.
Lin M; Gao P; Zhao T; He L; Li M; Li Y; Shui H; Wu X
Mol Biol Rep; 2016 May; 43(5):397-406. PubMed ID: 26968558
[TBL] [Abstract][Full Text] [Related]
14. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
Gangadharan Komala M; Gross S; Zaky A; Pollock C; Panchapakesan U
Nephrology (Carlton); 2016 May; 21(5):423-31. PubMed ID: 26375854
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
Huang H; Jiang Y; Mao G; Yuan F; Zheng H; Ruan Y; Wu T
J Sci Food Agric; 2017 Mar; 97(4):1359-1366. PubMed ID: 27363537
[TBL] [Abstract][Full Text] [Related]
16. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.
Nishiyama A; Yoshizumi M; Rahman M; Kobori H; Seth DM; Miyatake A; Zhang GX; Yao L; Hitomi H; Shokoji T; Kiyomoto H; Kimura S; Tamaki T; Kohno M; Abe Y
Kidney Int; 2004 Mar; 65(3):972-81. PubMed ID: 14871417
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
[TBL] [Abstract][Full Text] [Related]
18. ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice.
Tesch GH; Ma FY; Han Y; Liles JT; Breckenridge DG; Nikolic-Paterson DJ
Diabetes; 2015 Nov; 64(11):3903-13. PubMed ID: 26180085
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats.
Wang J; Huang H; Liu P; Tang F; Qin J; Huang W; Chen F; Guo F; Liu W; Yang B
Eur J Pharmacol; 2006 Dec; 553(1-3):297-303. PubMed ID: 17074319
[TBL] [Abstract][Full Text] [Related]
20. NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus.
Zhang Q; Wang J; Duan MT; Han SP; Zeng XY; Wang JY
Brain Res Bull; 2013 Oct; 99():132-9. PubMed ID: 24161765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
